What we stand for
We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, improving the health of individuals and populations.
What we stand for
We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, improving the health of individuals and populations.
Meet our founder – Nassib Chamoun
The kernel of the HDAI vision was planted decades ago and has been growing ever since. Our story begins in Lebanon more than four decades ago.
Creating a new life
During this time, Nassib met two men who would become his life-long friends and mentors: the late Bernard Lown, MD, pioneering cardiologist, humanitarian, and Nobel Peace Prize winner, and the late Charlie Zraket, former CEO of Mitre Corp. Both nurtured his love of data-driven problem solving and inspired him to focus his life’s work on finding insights to complex questions that will have a positive impact on society.
Discovering the power of data
In the 80’s at Harvard, Nassib worked on one of the earliest computers in the US, building computer-assisted pattern recognition tools on big data to analyze some of the first digitized cardiac signals. Since then, he has spent thousands of hours inside the mathematical intricacies of models in the service of finding new insights that drive better outcomes for patients.
He has applied his experience with sophisticated algorithms to bring scientific rigor to clinical trials, he has authored numerous patents, and collaborated on many scientific publications.
Looking ahead
The themes of Nassib’s story are integral to the HDAI story: curiosity, the search for answers in big data, and the tireless drive to support clinicians and the patients they serve. And now a new collective story is being written.
Inspired by Nassib’s journey and the passion he brings to the work every day, our experienced team of healthcare experts, data scientists, technologists, consultants, and implementation specialists are helping to achieve HDAI’s mission of improving health outcomes for all patients.
Identifying an opportunity
He saw an opportunity to make sense of the ever-growing healthcare encounter data to create a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients. The company is built on the analytic tools that Nassib knows from the ground up, from the inside out, and work he initiated over two decades ago.
We’re building something special here — an incredibly talented, diverse, and inclusive team where employees feel appreciated and welcomed.”
Margie Ahearn
VP HR
What drives us
To deploy a versatile analytic platform that creates a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients.
I have the deepest respect for clinical expertise and judgement, and I know that nothing we do should ever replace that. Enhance, augment, but never replace.”
Phil Devlin
COO
Team
Headquartered near Boston, we have a 20-year history of building and deploying predictive models to advance our mission of improving the health of populations and individuals. Our team has deep experience working within healthcare organizations as well as life science and medical technology, big data, enterprise software, and data security companies. We recognize the value of a diverse, equitable, inclusive and welcoming workplace.
Our team is committed to making a positive impact on US healthcare. As patients, caregivers, and family, we are passionate about enhancing the care experience. Our data scientists, researchers, analysts, developers, and customer support teams have one goal — to make a platform that is used by healthcare providers, value-based care networks, payers, and patients themselves to improve care delivery, especially for vulnerable populations.
HDAI is a place where kindness
matters.”
Carola Endicott
Customer Engagement and Marketing
I believe that the unique experience of our team allows for improving the healthcare system at a very wide scale, by applying the predictive analytics that have been developed here.”
Mike Bertrand
VP Product Development
I have the deepest respect for clinical expertise and judgement, and I know that nothing we do should ever replace that. Enhance, augment, but never replace.”
Phil Devlin
COO
Team
Headquartered near Boston, we have a 20-year history of building and deploying predictive models to advance our mission of improving the health of populations and individuals. Our team has deep experience working within healthcare organizations as well as life science and medical technology, big data, enterprise software, and data security companies. We recognize the value of a diverse, equitable, inclusive and welcoming workplace.
Our team is committed to making a positive impact on US healthcare. As patients, caregivers, and family, we are passionate about enhancing the care experience. Our data scientists, researchers, analysts, developers, and customer support teams have one goal — to make a platform that is used by healthcare providers, value-based care networks, payers, and patients themselves to improve care delivery, especially for vulnerable populations.
HDAI is a place where kindness matters.”
Carola Endicott
Customer Engagement and Marketing
I believe that the unique experience of our team allows for improving the healthcare system at a very wide scale, by applying the predictive analytics that have been developed here.”
Mike Bertrand
VP Product Development
By providing Bloomberg-like insights and analytics, HDAI has more potential to drive improvement in the healthcare system to the benefit of patients, providers, and payors than any project I’ve worked on in my 4 decades as a venture capital investor.
Edwin Kania
Co-Founder
Board of Directors
We are backed by investors and advisors who share our vision and keep us focused on our mission to extract value from health data and revolutionize its use for the good of society. Our board members come from finance, medical device, health IT, research and academia, and they are committed to helping us get it right.
I believe that the unique experience of our team allows for improving the healthcare system at a very wide scale, by applying the predictive analytics that have been developed here.”
Mike Bertrand
VP Product Development
John O’Connor is the former vice chairman of services for PricewaterhouseCoopers. He also serves on several corporate boards. He received a BA from Suffolk University and an MBA from the Amos Tuck School at Dartmouth College. He graduated from the Harvard Business School’s Leadership in Professional Service Firms program.
Edwin Kania is the co-founder of Flagship Pioneering, a leading life sciences venture firm. He has 35 years of experience in the venture capital industry. Mr. Kania has worked with entrepreneurs and invested in over 100 companies valued at over $10 billion. He received a BS in physics from Dartmouth College and an MBA from Harvard Business School.
Kenneth Froot is a founding partner of FDO Partners, LLC, State Street Associates and MKT MediaStats. Mr. Froot is a professor at Harvard University. He received a BA from Stanford University and a Ph.D. from the University of California at Berkeley. His research on various financial topics has been widely published.
Marcus Traill began his career as an analyst at Bank of New Zealand and Owens Group prior to joining the McPike Global Family Office (MGFO). At QuantRes, part of the MGFO, he has played key roles in the trading of various quantitative strategies and was responsible for managing the operations of the group. As co-head of Private Investments he oversaw the MGFO private investment strategy. He is now a Founding Partner at Altered Capital, a venture capital and reinvestment stage fund manager focused on private growth companies pursuing strategies in technology, healthcare, and financials. He remains a close advisor to MGFO and serves as an Investor Director at Starling Bank, a UK regulated digital bank.
By providing Bloomberg-like insights and analytics, HDAI has more potential to drive improvement in the healthcare system to the benefit of patients, providers, and payors than any project I’ve worked on in my four decades as a venture capital investor.
